Author/Authors :
Gilany, Kambiz Reproductive Biotechnology Research Center - Avicenna Research Institute - ACECR, Tehran - Integrative Oncology Department - Breast Cancer Research Center - Motamed Cancer Institute - ACECR, Tehran , Mohamadkhani, Ashraf Digestive Diseases Research Center - Digestive Diseases Research Institute - Tehran University of Medical Sciences , Chashmniam, Saeed Department of Chemistry - Sharif University of Technology, Tehran , Shahnazari, Parisa Reproductive Biotechnology Research Center - Avicenna Research Institute - ACECR, Tehran , Amini, Mehdi Reproductive Biotechnology Research Center - Avicenna Research Institute - ACECR, Tehran , Arjmand, Babak Cell Therapy and Regenerative Medicine Research Center - Endocrinology and Metabolism Molecular Cellular Sciences Institute - Tehran University of Medical Sciences , Malekzadeh, Reza Digestive Diseases Research Center - Digestive Diseases Research Institute - Tehran University of Medical Sciences , Nobakht Motlagh Ghoochani, Bibi Fatemeh Noncommunicable Diseases Research Center - Neyshabur University of Medical Sciences, Neyshabur - Department of Basic Medical Sciences - Neyshabur University of Medical Sciences
Abstract :
Objective(s): Hepatitis B virus infection causes chronic disease such as cirrhosis and hepatocellular
carcinoma. The metabolomics investigations have been demonstrated to be related to pathophysiologic
mechanisms in many disorders such as hepatitis B infection. The aim of this study was to investigate
the saliva metabolic profile of patients with chronic hepatitis B infection and to identify underlying
mechanisms as well as potential biomarkers associated with the disease.
Materials and Methods: Saliva from 16 healthy subjects and 20 patients with chronic hepatitis B virus
were analyzed by nuclear magnetic resonance (NMR). Then, multivariate statistical analysis was
performed to identify discriminative metabolites between two groups.
Results: A set of metabolites were detected, including propionic acid, putrescine, acetic acid, succinic
acid, tyrosine, lactic acid, butyric acid, pyruvic acid, 4-pyridoxic acid and 4-hydroxybenzoic acid,
which in combination with one another could accurately distinguish patients from healthy controls.
Our results clearly demonstrated altered metabolites are involved in nine metabolic pathways.
Conclusion: Metabolomics has the potential to be considered as a novel clinical tool for hepatitis B
diagnosis while contributing to a comprehensive understanding of disease mechanisms.
Keywords :
Diagnostic biomarkers , Hepatitis B virus , Metabolomics , NMR , Saliva